A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Clinical trial NCT02925403 · COMPLETED
Trial details
- NCT number
- NCT02925403
- Sponsor
- University of Oxford
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-26
- Primary completion
- 2017-02-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.